

Please try another search
Wells Fargo raised JPMorgan shares to Overweight amid larger turmoil in the banking sector. And here is today's full Pro Recap of the biggest analyst upgrades and downgrades over the past...
Exelixis (NASDAQ:EXEL), Inc. EXEL and partner Aurigene announced that the former has exercised its exclusive option for the latter’s novel CDK7 inhibitor under their 2019 agreement.As a result,...
Gilead Sciences (NASDAQ:GILD), Inc.’s GILD Kite announced results from the interim analysis of ZUMA-12, a multicenter, open-label, single-arm phase II study evaluating Yescarta (axicabtagene...
Roche RHHBY (OTC:RHHBY) announced that the FDA has approved the label expansion of asthma drug, Xolair. The agency approved the company’s supplemental Biologics License Application (sBLA) for...
Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. REGN and partner Sanofi (NASDAQ:SNY) SNY announced that the European Commission (EC) has extended the marketing authorization for asthma drug,...
Kodiak Sciences (NASDAQ:KOD) Inc. KOD announced that it has completed enrollment in the pivotal phase IIb/III DAZZLE study, which is evaluating its lead pipeline candidate KSI-301 for the treatment of...
Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ) JNJ, announced that it has submitted regulatory applications to the FDA and European Medicines Agency ("EMA"), seeking a label expansion of...
One stock that might be an intriguing choice for investors right now is Halozyme Therapeutics, Inc. (NASDAQ:HALO) . This is because this security in the Medical - Biomedical and Genetics space is...
Trevena, Inc. (NASDAQ:TRVN) announced that the FDA has accepted its new drug application seeking approval for intravenous (“IV”) oliceridine for management of moderate-to-severe acute...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review